Literature DB >> 9883906

Engineering of chicken avidin: a progressive series of reduced charge mutants.

A T Marttila1, K J Airenne, O H Laitinen, T Kulik, E A Bayer, M Wilchek, M S Kulomaa.   

Abstract

Avidin, a positively charged egg-white glycoprotein, is a widely used tool in biotechnological applications because of its ability to bind biotin strongly. The high pI of avidin (approximately 10.5), however, is a hindrance in certain applications due to non-specific (charge-related) binding. Here we report a construction of a series of avidin charge mutants with pIs ranging from 9.4 to 4.7. Rational design of the avidin mutants was based on known crystallographic data together with comparative sequence alignment of avidin, streptavidin and a set of avidin-related genes which occur in the chicken genome. All charge mutants retained the ability to bind biotin tightly according to optical biosensor interaction analysis. In most cases, their thermal stability characteristics were indistinguishable from those of the wild-type avidin. Our results demonstrate that the charge properties of avidin can be modified without disturbing the crucial biotin-binding activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9883906     DOI: 10.1016/s0014-5793(98)01570-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Tetravalent single-chain avidin: from subunits to protein domains via circularly permuted avidins.

Authors:  Henri R Nordlund; Vesa P Hytönen; Jarno Hörhä; Juha A E Määttä; Daniel J White; Katrin Halling; Eevaleena J Porkka; J Peter Slotte; Olli H Laitinen; Markku S Kulomaa
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

2.  Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin.

Authors:  Olli H Laitinen; Vesa P Hytönen; Mervi K Ahlroth; Olli T Pentikäinen; Ciara Gallagher; Henri R Nordlund; Vladimir Ovod; Ari T Marttila; Eevaleena Porkka; Sanna Heino; Mark S Johnson; Kari J Airenne; Markku S Kulomaa
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment.

Authors:  Vesa P Hytönen; Olli H Laitinen; Alessandro Grapputo; Anu Kettunen; Janne Savolainen; Nisse Kalkkinen; Ari T Marttila; Henri R Nordlund; Thomas K M Nyholm; Giovanni Paganelli; Markku S Kulomaa
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

4.  Mutation of the important Tyr-33 residue of chicken avidin: functional and structural consequences.

Authors:  Ari T Marttila; Vesa P Hytönen; Olli H Laitinen; Edward A Bayer; Meir Wilchek; Markku S Kulomaa
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

5.  Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.

Authors:  Antonio Verdoliva; Piero Bellofiore; Vincenzo Rivieccio; Sergio Catello; Maurizio Colombo; Claudio Albertoni; Antonio Rosi; Barbara Leoni; Anna Maria Anastasi; Rita De Santis
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

6.  Avidin related protein 2 shows unique structural and functional features among the avidin protein family.

Authors:  Vesa P Hytönen; Juha A E Määttä; Heidi Kidron; Katrin K Halling; Jarno Hörhä; Tuomas Kulomaa; Thomas K M Nyholm; Mark S Johnson; Tiina A Salminen; Markku S Kulomaa; Tomi T Airenne
Journal:  BMC Biotechnol       Date:  2005-10-07       Impact factor: 2.563

7.  PClass: Protein Quaternary Structure Classification by Using Bootstrapping Strategy as Model Selection.

Authors:  Chi-Chou Huang; Chi-Chang Chang; Chi-Wei Chen; Shao-Yu Ho; Hsung-Pin Chang; Yen-Wei Chu
Journal:  Genes (Basel)       Date:  2018-02-14       Impact factor: 4.096

8.  Avidin-biotin technology to synthesize multi-arm nano-construct for drug delivery.

Authors:  Chenzhen Zhang; Tengfei He; Armin Vedadghavami; Ambika G Bajpayee
Journal:  MethodsX       Date:  2020-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.